Daiichi Sankyo settles its cardio drug lawsuit with Esperion, which will get $125M milestone payment
Daiichi Sankyo Europe and Esperion Therapeutics have agreed to a $125 million change to their collaboration agreement, settling a legal dispute …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
